Abstract:Rationale & Objective: In populations with folic acid fortification or supplementation, the main nutritional determinant of total homocysteine levels is vitamin B-12 (B12) status. We aimed to evaluate the modifying effect of B12 levels on the association between folic acid treatment and chronic kidney disease (CKD) progression. Study Design: A post hoc analysis of an interventional trial. Setting & Participants: This is a post hoc analysis of 1,374 hypertensive adults with mild to moderate CKD and B12 measurements at baseline from the kidney disease substudy of the China Stroke Primary Prevention Trial (CSPPT), conducted in 20 communities in Jiangsu province in China, a region with low folate consumption. Interventions: Assignments to a double-blinded daily treatment of enalapril, 10 mg, and folic acid, 0.8 mg; or enalapril, 10 mg, alone. Outcomes: The primary outcome was progression of CKD (defined as a decrease in estimated glomerular filtration rate [eGFR] >= 30% and to a level of <60 mL/min/1.73 m(2) if baseline eGFR was >= 60 mL/min/1.73 m(2); or a decrease in eGFR >= 50% if baseline eGFR was <60 mL/min/ 1.73 m(2); or kidney failure). Results: Mean baseline eGFR in this study was 86.1 +/- 20.5 (SD) mL/min/1.73 m(2). Median treatment duration was 4.4 years. Among participants with higher baseline B12 levels (>= 248 pmol/L), compared to enalapril alone, enalapril-folic acid treatment was associated with an 83% reduction in the odds of the primary outcome (OR, 0.17; 95% CI, 0.07-0.40). However, among those with baseline B12 levels < 248 pmol/L (metabolic B12 deficiency), there was no significant group difference in the primary outcome (OR, 1.21; 95% CI, 0.51-2.85). The interaction between B12 level and folic acid treatment was significant (P = 0.001). Limitations: The analysis is post hoc and event rate is low. Conclusions: Folic acid treatment was associated with a greater reduction in the odds of CKD progression among patients with mild to moderate CKD and higher B12 levels.

Effect of Vitamin B on Hyperhomocysteinemia in Renal-Transplant Recipients

Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population

The clinical signficance of application of folic acid and vitamin B group in patients with coronary heart disease and heart failure associated with homocystinemia

Relationship between plasma levels of homocysteine and the related B vitamins in patients with hemodialysis adequacy or inadequacy

Influencing Factors of Hyperhomocysteinemia and Effect of High Dose Folic Acid Treatment in Maintenance Hemodialysis Patients

Influence of Folic Acid and B-vitamins on Left Ventricular Remodeling and Cardiac Function in AMI Patients with Hyperhomocysteinemia

Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial.

A tale of two homocysteines--and two hemodialysis units

Effect of Vitamin B_12 and N-3 Polyunsaturated Fatty Acids on Plasma Homocysteine, Ferritin, C-Reaction Protein, and Other Cardiovascular Risk Factors: a Randomized Controlled Trial

Effect of acute humoral rejection on renal allograft survival

Effect of Folic Acid on Endothelial Function and Plasma Homocysteine in Hypertensive Patients

Effect of Allitridum on Free Radical Metabolism in Hyperhomocysteinemia Rats

[The Effect of Baseline Homocysteine Level on the Efficacy of Enalapril Maleate and Folic Acid Tablet in Lowering Blood Pressure and Plasma Homocysteine].

The efficacy of folic acid on improving endothelial cell function in the treatment of patients with homocysteine:A Me-ta-analysis

Effects of Low-Dose B Vitamins Plus Betaine Supplementation on Lowering Homocysteine Concentrations among Chinese Adults with Hyperhomocysteinemia: a Randomized, Double-Blind, Controlled Preliminary Clinical Trial.

[Effect of Low-Dose Folate Treatment on Plasma Homocystyeine and Chemokine Levels in Patients with Hyperhomocysteinemia].

Vitamin D Supplementation Could Reduce the Risk of Acute Cellular Rejection and Infection in Vitamin D Deficient Liver Allograft Recipients

Effect of folacin and mecobalamine on plasma homocysteine nitric oxide and urinary albumin in patients with diabetic nephropathy

Vitamin C improves endothelial dysfunction in renal allograft recipients

The Relationships Between Hyperhomocysteinemia and Folic Acid,vitamin B12 and Vitamin B6

The Effects of Oral Vitamin Con Microinflammatory State in Hemodialysis Patients